Company Filing History:
Years Active: 2009
Title: The Innovations of Inventor Jing Shang
Introduction
Jing Shang, an accomplished inventor based in Fishers, IN, has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative solutions for critical health issues, her work exemplifies dedication to improving patient outcomes.
Latest Patents
Shang holds a patent for "Muteins of fibroblast growth factor 21" which relates to novel muteins of human fibroblast growth factor 21 with enhanced pharmaceutical properties. This invention includes both the protein and the respective encoding nucleic acid species. Furthermore, it encompasses vectors and host cells used for the propagation of these nucleic acid sequences, as well as methods for producing the muteins. This groundbreaking work also emphasizes treatments for type 2 diabetes, obesity, metabolic syndrome, and aims to reduce the mortality and morbidity of critically ill patients.
Career Highlights
Jing Shang is currently employed at Eli Lilly and Company, a leading pharmaceutical firm recognized for its innovations in healthcare. Her career has been marked by her commitment to advancing therapeutic capabilities through her patents and research efforts.
Collaborations
Throughout her career, Jing has had the opportunity to collaborate with notable colleagues, including John Michael Beals and Christopher Carl Frye. These partnerships have played a vital role in her research initiatives, combining diverse expertise to address significant medical challenges.
Conclusion
In summary, Jing Shang's contributions to the field of pharmaceuticals through her innovative patent and collaborations underscore her impact as an inventor. Her work not only highlights the importance of advancing medical treatments but also reflects her commitment to enhancing the quality of care for patients facing serious health conditions.